1Y Close · As of Aug 26, 2026
시스웍 operates in the Medical, Precision & Optical sector.
In fiscal year 2025, 시스웍 (269620) reported revenue of 11.0 billion KRW, down 14.2% from 12.9 billion KRW a year earlier.
Operating profit was -2.6 billion KRW and net income was -5.1 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 149 million KRW.
These figures can be verified in the DART filing (receipt no. 20260331004903).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 11.0B | -2.6B | -5.1B |
| 2024 | 12.9B | -1.8B | -9.4B |
| 2023 | 14.5B | -3.0B | -6.1B |
Recent Filings
Large Shareholding Report (Simplified)
기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)
Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B)
Checks
4 of 8 checked items currently applicable.
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-24 | Large Shareholding Report (Simplified) |
| 2026-08-14 | 기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행) |
| 2026-08-14 | Semi-Annual Review Adverse Opinion (Capital Erosion 50%+ or Equity Below 1B) |
| 2026-08-14 | Semi-Annual Report (2026.06) |
| 2026-08-11 | 주권매매거래정지해제 (상장폐지에 따른 정리매매 개시) |